What outcomes are important to patients with mild cognitive impairment or Alzheimer's disease, their caregivers, and health-care professionals? A systematic review.
Activities of daily living
Alzheimer's Disease
Autonomy
Burden
Caregivers
Healthcare professionals
Memory
Mild cognitive impairment
Outcomes
Patients
Qualitative
Quality of life
Quantitative
Systematic review
Journal
Alzheimer's & dementia (Amsterdam, Netherlands)
ISSN: 2352-8729
Titre abrégé: Alzheimers Dement (Amst)
Pays: United States
ID NLM: 101654604
Informations de publication
Date de publication:
Dec 2019
Dec 2019
Historique:
entrez:
26
3
2019
pubmed:
25
3
2019
medline:
25
3
2019
Statut:
epublish
Résumé
Clinical trials involving patients with Alzheimer's disease (AD) continue to try to identify disease-modifying treatments. Although trials are designed to meet regulatory and registration requirements, many do not measure outcomes of the disease most relevant to key stakeholders. A systematic review sought research that elicited information from people with AD, their caregivers, and health-care professionals on which outcomes of the disease were important. Studies published in any language between 2008 and 2017 were included. Participants in 34 studies described 32 outcomes of AD. These included clinical (memory, mental health), practical (ability to undertake activities of daily living, access to health information), and personal (desire for patient autonomy, maintenance of identity) outcomes of the disease. Evidence elicited directly from the people most affected by AD reveals a range of disease outcomes that are relevant to them but are not commonly captured in clinical trials of new treatments.
Identifiants
pubmed: 30906845
doi: 10.1016/j.dadm.2018.12.003
pii: S2352-8729(18)30085-X
pmc: PMC6411507
doi:
Types de publication
Journal Article
Langues
eng
Pagination
231-247Références
PLoS One. 2013;8(1):e53928
pubmed: 23326541
Qual Health Res. 2010 Mar;20(3):293-305
pubmed: 19940091
Alzheimers Res Ther. 2016 Nov 21;8(1):48
pubmed: 27866472
Int Psychogeriatr. 2014 Mar;26(3):475-85
pubmed: 24284179
Health Technol Assess. 2017 May;21(26):1-192
pubmed: 28625273
J Caring Sci. 2013 Aug 27;2(3):187-95
pubmed: 25276726
Sociol Health Illn. 2008 Apr;30(3):396-412
pubmed: 18298633
Innov Clin Neurosci. 2017 Feb 01;14(1-2):22-29
pubmed: 28386518
Neurol Ther. 2016 Dec;5(2):183-192
pubmed: 27506698
Alzheimers Dement. 2016 Jan;12(1):75-84
pubmed: 26079412
Physiotherapy. 2014 Jun;100(2):169-75
pubmed: 24530168
Gerontologist. 2016 Jun;56(3):451-60
pubmed: 25614608
J Neurosci Nurs. 2011 Dec;43(6):317-28
pubmed: 22089409
Curr Alzheimer Res. 2009 Aug;6(4):384-91
pubmed: 19689238
Ther Innov Regul Sci. 2017 May;51(3):380-390
pubmed: 30231712
Value Health. 2017 Jul - Aug;20(7):858-865
pubmed: 28712614
Clin Pharmacol Ther. 2011 Nov;90(5):737-42
pubmed: 21975345
Alzheimers Dement. 2018 Apr;14(4):535-562
pubmed: 29653606
Qual Life Res. 2014 Aug;23(6):1813-21
pubmed: 24448684
Dementia (London). 2015 Jan;14(1):63-79
pubmed: 24339090
J Neurol Neurosurg Psychiatry. 2010 Dec;81(12):1363-8
pubmed: 20881017
J Nutr Health Aging. 2010 Aug;14(7):525-30
pubmed: 20818466
Int J Geriatr Psychiatry. 2010 Feb;25(2):191-201
pubmed: 19548273
Gerontologist. 2009 Jun;49 Suppl 1:S40-9
pubmed: 19525216
Am J Alzheimers Dis Other Demen. 2010 May;25(3):239-47
pubmed: 20147602
J Neurol Neurosurg Psychiatry. 2012 Feb;83(2):171-3
pubmed: 22019547
Alzheimers Dement (N Y). 2017 May 10;3(3):314-322
pubmed: 29067338
Alzheimers Dement. 2008 Sep;4(5):345-52
pubmed: 18790461
BMC Res Notes. 2016 Mar 08;9:149
pubmed: 26956520
Gerontologist. 2010 Feb;50(1):11-22
pubmed: 19491355
Australas Psychiatry. 2008 Dec;16(6):433-7
pubmed: 18777227
Int J Geriatr Psychiatry. 2008 Feb;23(2):148-54
pubmed: 17578843
Lancet. 2016 Jul 30;388(10043):505-17
pubmed: 26921134
Lancet Neurol. 2016 Apr;15(5):455-532
pubmed: 26987701